أعرض تسجيلة المادة بشكل مبسط
| dc.contributor |
GF Jooste Hospital, Cape Town, South Africa. davestead@mweb.co.za |
|
| dc.creator |
Stead, D |
|
| dc.creator |
Osler, M |
|
| dc.creator |
Boulle, A |
|
| dc.creator |
Rebe, K |
|
| dc.creator |
Meintjes, G |
|
| dc.date |
2008-11 |
|
| dc.date.accessioned |
2017-01-31T07:12:56Z |
|
| dc.date.available |
2017-01-31T07:12:56Z |
|
| dc.identifier |
Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa. 2008, 13 (7):937-43 Antivir. Ther. (Lond.) |
|
| dc.identifier |
1359-6535 |
|
| dc.identifier |
19043928 |
|
| dc.identifier |
http://hdl.handle.net/10144/41770 |
|
| dc.identifier |
http://fieldresearch.msf.org/msf/handle/10144/41770 |
|
| dc.identifier |
Antiviral therapy |
|
| dc.identifier.uri |
http://dspace.mediu.edu.my:8181/xmlui/handle/10144/41770 |
|
| dc.description |
BACKGROUND: In the public sector antiretroviral therapy (ART) programme in South Africa the standardized first-line regimen includes stavudine (d4T). Severe symptomatic hyperlactataemia (SHL) is a potentially life-threatening complication of d4T. METHODS: GF Jooste Hospital is a referral centre for six ART clinics. We retrospectively reviewed cases referred with lactate levels > or =5 mmol/l that were attributed to nucleoside reverse transcriptase inhibitors from August 2003 to November 2005. We calculated cumulative ART exposure in patients attending these clinics to derive a referral rate. RESULTS: In total, 75 patients were referred with severe SHL (71 female). All had been on d4T and on ART for a median of 10 months. The referral rate for severe SHL was 17.5 cases per 1,000 patient-years. In 53 patients (71%), lactic acidosis (standard bicarbonate [SHCO3] <20 mmol/l) was confirmed, resulting in a referral rate of 12.3 cases per 1,000 patient-years. Twelve patients (16%) died during acute admission (< or =30 days). SHCO3 <15 mmol/l and pH < 7.2 were the only factors associated with acute mortality (odds ratio [OR] 22.5, 95% confidence interval [CI] 2.8-1,045.7 and OR 13.9, 95% CI 2.7-86.9, respectively). A total of 30 less severe cases were rechallenged with zidovudine without recurrence of SHL. CONCLUSIONS: This study confirms a high incidence of severe SHL in Africa, which has been shown in previous studies. Rechallenge with zidovudine in less severe cases was found to be safe. |
|
| dc.language |
en |
|
| dc.relation |
http://www.intmedpress.com |
|
| dc.rights |
Archived on this site with kind permission of International Medical Press. http://www.intmedpress.com |
|
| dc.title |
Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa. |
|
الملفات في هذه المادة
|
لا توجد أي ملفات مرتبطة بهذه المادة.
|
هذه المادة تبدو في المجموعات التالية:
أعرض تسجيلة المادة بشكل مبسط